missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
STEMCELL Technologies BIRB-796
Beskrivning
- BIRB-796 is a highly potent inhibitor of p38 MAPK (Kd = 0.1 nM) that blocks TNFα release in LPS-stimulated THP-1 cells (IC50 = 18 nM) (Pargellis et al.) At 10 μM, BIRB-796 can also inhibit JNK2α2 in vitro, but at lower concentrations BIRB-796 inhibits p38 MAPK without affecting phosphorylation of JNK substrates (Bain et al.; Kuma et al.)
- Rescues the self-renewal ability of muscle satellite cells from aged mice (Bernet et al.)
- Increases the regenerative capacity of functional aged skeletal muscle stem cells grown in hydrogel (Cosgrove et al.)
- Blocks GADD45G-induced differentiation of long-term repopulating hematopoietic stem cells (Thalheimer et al.)
- Enhances stem cell activity of cultured umbilical cord blood-derived hematopoietic cells cultured in serum-free medium supplemented with SCF, TPO, and FLT3L (Baudet et al.)
- Blocks the osteogenic differentiation effect of myocilin on human mesenchymal stem cells (Kwon et al.)
Specifikationer
Specifikationer
| CAS | 285983-48-4 |
| Synonym | Doramapimod |
| Kvantitet | 1 mg |
| Molekylformel | C31H37N5O3 |
| Renhet | ≥98% |
Produkttitel
Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.
Hittar du en möjlighet till förbättring?